SCHEMBL31441629

SCHEMBL31441629

CC1(C)OB(c2cccnc2OCC2CCC2)OC1(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 2/20 0.37
▸ CCNA2 P20248 2/20 0.33
▸ CDK2 P24941 2/20 0.33
▸ CCNA1 P78396 2/20 0.33
▸ CHRNB4 P30926 2/20 0.33
▸ CHRNA3 P32297 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ EDNRA P25101 1/20 0.33
▸ HTR4 Q13639 2/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ HTR3A P46098 1/20 0.33
▸ MCHR1 Q99705 1/20 0.32
▸ GRM4 Q14833 1/20 0.32
▸ LIPE Q05469 1/20 0.32
▸ ALOX5AP P20292 1/20 0.32
▸ FEN1 P39748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12098073 0.95 ALOX5AP (0.35) FFAR4CHRNB4CHRNA3ACHECNR1
SCHEMBL31441507 0.82 ROCK2 (0.40) FFAR4ROCK2LIPEALOX5APFEN1
SCHEMBL29900384 0.79 L3MBTL1 (0.36) LIPE
SCHEMBL365301 0.79 L3MBTL1 (0.36) LIPE
SCHEMBL31441748 0.79 ROCK2 (0.40) FFAR4ROCK2ALOX5APFEN1
SCHEMBL22040325 0.79 ROCK2 (0.41) ROCK2LIPEALOX5APFEN1
SCHEMBL29513574 0.79 ROCK2 (0.41) ROCK2LIPEALOX5APFEN1
SCHEMBL25429896 0.78 ROCK2 (0.40) FFAR4ROCK2ALOX5APFEN1
SCHEMBL9998673 0.77 LPL (0.36) ROCK2LIPE
SCHEMBL30138169 0.77 LPL (0.36) ROCK2LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270222-A1 AP2 ASSOCIATED KINASE 1 INHIBITORS AND USES THEREOF SATELLOS BIOSCIENCE INC. (CA) 2025-08-28 — — US disclosed
US-20250122207-A1 AP2 ASSOCIATED KINASE 1 INHIBITORS AND USES THEREOF SATELLOS BIOSCIENCE INC. (CA) 2025-04-17 — — US disclosed
WO-2025054448-A1 AP2 ASSOCIATED KINASE 1 INHIBITORS AND USES THEREOF SATELLOS BIOSCIENCE INC. (CA) 2025-03-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122207-A1 AP2 ASSOCIATED KINASE 1 INHIBITORS AND USES THEREOF AAK1, CAMKK1, AP2A1 FFAR4 2270/4885CCNA2 4463/4885CDK2 875/4885
US-20250270222-A1 AP2 ASSOCIATED KINASE 1 INHIBITORS AND USES THEREOF AAK1, AP2A1, CSNK1A1 FFAR4 1991/4885CCNA2 4396/4885CDK2 665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback